Receptor activation is dependent upon receptor and ligand availability, and although we do not observe a significant decrease in androgen receptor levels in the same tumour specimens, an increasing number of reports link low levels of circulating androgens to aggressive pathological features and worse outcome, although the findings are not universal [19]. The gene discussed is AR; the disease is neoplasm.